A double-blind, multi-center, dose comparison study of TTC-909 for the treatment of peripheral vascular disorders.
Esato
K
K
First Department of Surgery, Yamaguchi University School of Medicine, Japan.
D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D011464:Epoprostenol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D010146:Pain; D016491:Peripheral Vascular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D014456:Ulcer / Q000188:drug therapy
C068518:TTC 909; D011464:Epoprostenol